NCT00983021 - Safety and Tolerability of NN9068 in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

DiabetesHealthy

Interventions

DRUG

insulin degludec/liraglutide

Single, simultaneous dose of NN9068, injected s.c. (under the skin)

DRUG

insulin degludec

Single, simultaneous dose of NN1250, injected s.c. (under the skin)

DRUG

liraglutide

Single, simultaneous dose of NN2211, injected s.c. (under the skin)

DRUG

placebo

Single, simultaneous dose of placebo, injected s.c. (under the skin)

Trial Locations (1)

Novo Nordisk Investigational Site, Neuss